Bit Capital Gmb H Oncternal Therapeutics, Inc. Transaction History

Bit Capital Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Feb 12, 2025	BUY	$0.63 - $1.3 $142,668 - $294,395	226,458 Added 44.67%	733,458 $566 Million
Q4 2022 Feb 12, 2025	BUY	$0.86 - $22.2 $41,711 - $1.08 Million	48,502 Added 10.58%	507,000 $451 Million
Q3 2022 Feb 12, 2025	BUY	$0.83 - $17.8 $34,443 - $738,664	41,498 Added 9.95%	458,498 $406 Million
Q2 2022 Feb 12, 2025	BUY	$0.7 - $1.56 $291,900 - $650,520	417,000 New	417,000 $453 Million

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.